title: Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.
abstract: Indomethacin is a non steroidal anti-inflammatory agent widely employed in the treatment of premature contractions. Indomethycin induced oligohydramnios is a well described side-effect, and is considered an indication for treatment discontinuation. We present a case of prolonged anhydramnios, secondary to indomethacin therapy with no apparent ill-effect on the fetus or neonate.
authors.affiliation: Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: O
authors.initials: O
authors.lastname: Shen
authors.forename: R
authors.initials: R
authors.lastname: Rabinowitz
authors.forename: O
authors.initials: O
authors.lastname: Lavie
authors.forename: Y
authors.initials: Y
authors.lastname: Aboulafia
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Diamant
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects* / Q000627:therapeutic use; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D016104:Oligohydramnios / Q000139:chemically induced* / Q000175:diagnosis; D011247:Pregnancy; D011256:Pregnancy Outcome; D015149:Tocolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D015149:Tocolytic Agents; D007213:Indomethacin